Dysregulated expression of IL-17A and IL-17F is associated with chronic inflammatory diseases such as psoriasis, psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, and asthma (17–20). Here, IL17A is linked to rheumatoid arthritis.